Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

2.70
-1.0500-28.00%
Post-market: 2.790.0900+3.33%19:59 EST
Volume:2.28M
Turnover:6.63M
Market Cap:8.37M
PE:-0.08
High:3.50
Open:3.50
Low:2.52
Close:3.75
Loading ...

BRIEF-Bioxcel Therapeutics Announces Closing Of $14 Million Registered Direct Offering

Reuters
·
6 hours ago

BioXcel Therapeutics Announces Closing of $14 Million Registered Direct Offering

THOMSON REUTERS
·
7 hours ago

BioXcel Therapeutics, Inc. (BTAI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Zacks
·
Yesterday

BioXcel Therapeutics Announces $14 Million Registered Direct Offering

THOMSON REUTERS
·
Yesterday

Press Release: BioXcel Therapeutics Announces $14 Million Registered Direct Offering

Dow Jones
·
Yesterday

Top Midday Gainers

MT Newswires Live
·
Yesterday

BioXcel Therapeutics Inc - FDA Designates 'Voluntary Action Indicated' for Tranquility Ii Site

THOMSON REUTERS
·
03 Mar

BioXcel Therapeutics Inc - Believes FDA Report Supports Tranquility Ii Data Reliability

THOMSON REUTERS
·
03 Mar

BioXcel Therapeutics Announces FDA Closed Its Inspection of Site for Phase 3 Tranquility Ii Trial for Acute Treatment of Agitation Associated With Alzheimer’s Dementia

THOMSON REUTERS
·
03 Mar

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
01 Mar

BioXcel Therapeutics Regains Nasdaq Compliance

MT Newswires Live
·
28 Feb

Wall Street Set to Open Higher Friday as Inflation Data Meets Expectations

MT Newswires Live
·
28 Feb

US Stock Futures Rise as Investors Await Key Inflation Data

MT Newswires Live
·
28 Feb

Top Premarket Gainers

MT Newswires Live
·
28 Feb

BioXcel Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Rule

THOMSON REUTERS
·
28 Feb

BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule

GlobeNewswire
·
28 Feb